JP Patent

JP2004532209A — ５−ｈｔ６受容体の拮抗薬としてのｎ−（２−アリールエチル）ベンジルアミン

Assigned to Eli Lilly and Co · Expires 2004-10-21 · 22y expired

What this patent protects

本発明は、5-HT 6 受容体のアンタゴニストである式Ｉ【化１】の化合物を提供する。

USPTO Abstract

本発明は、5-HT 6 受容体のアンタゴニストである式Ｉ【化１】の化合物を提供する。

Drugs covered by this patent

Patent Metadata

Patent number: JP2004532209A
Jurisdiction: JP
Classification: —
Expires: 2004-10-21
Drug substance claim: No
Drug product claim: No
Assignee: Eli Lilly and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.